Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Are beta-blockers really depressogenic?]

A Pélissolo1, F Héloire

  • 1Service de Psychiatrie, Hôpital Fernand-Widal, Paris.

Annales Medico-Psychologiques
|August 1, 1995
PubMed
Summary

Systemic beta-blockers, used for over 25 years, have been controversially linked to depression. While some studies suggest a connection, prospective research has not confirmed this association, highlighting the need for further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EEG Neurofeedback for Anxiety Disorders and Post-Traumatic Stress Disorders: A Blueprint for a Promising Brain-Based Therapy.

Current psychiatry reports·2021
Same author

[Is the medication reconciliation achievable and relevant in Psychiatry?: Feedback on the implementation of medication reconciliation on hospital admission].

Annales pharmaceutiques francaises·2019
Same author

[Mindful neuropsychology: Mindfulness-based cognitive remediation].

L'Encephale·2017
Same author

[Mindfulness-based interventions in obsessive-compulsive disorder: Mechanisms of action and presentation of a pilot study].

L'Encephale·2016
Same author

[Can the efficacy of behavioral and cognitive therapy for obsessive compulsive disorder be augmented by innovative computerized adjuvant?]

L'Encephale·2016
Same author

Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.

Psychopharmacology·2015

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Psychiatry

Context:

  • Systemic beta-blockers are widely prescribed for cardiovascular diseases and other conditions.
  • Reports suggest a potential link between beta-blocker use and clinical depression.
  • Existing research presents conflicting findings regarding this association.

Purpose:

  • To review and analyze the evidence regarding the association between beta-blocker use and depression.
  • To explore the discrepancies between retrospective and prospective studies on this topic.
  • To identify potential clinical, methodological, and pharmacological factors contributing to the conflicting results.

Summary:

  • Over 25 years of beta-blocker use have generated reports linking them to depression.
  • Retrospective studies sometimes show a positive association.
  • However, limited longitudinal prospective studies have failed to confirm this link.

Impact:

  • The discrepancies in findings warrant further investigation into the complex relationship between beta-blockers and depression.
  • Understanding these issues is crucial for accurate risk-benefit assessments in clinical practice.
  • This review highlights the need for robust research methodologies to resolve the ongoing debate.

Related Experiment Videos